{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:11Z","timestamp":1790224451721,"version":"4.1.0"},"reference-count":26,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: This study aims to evaluate survival, relapse, comorbidities, and prognostic factors in patients with thymic epithelial tumours (TETs) to improve risk stratification for TET-related mortality and relapse and support evidence-based follow-up and treatment strategies.Patient\/material and methods: The cohort consists of consecutive Danish patients diagnosed with thymoma, thymic carcinoma (TC), or thymic neuroendocrine tumor (NET) between January 1st, 2015 and December 31st, 2020, with follow-up data available.Data were collected from online medical records including disease characteristics, survival outcomes, comorbidities, and relapse. Statistical analyses were performed in R 4.3.2 and the prognostic value baseline traits were analyzed using Cox Proportional Hazards models.Results: Our cohort comprised 282 patients with a mean diagnostic age of 65 years and the following histological distribution: thymoma (85%), TC (13.6%), and NET (1.4%). During the 72-month mean follow-up, 65 deaths occurred yielding overall survival (OS) of 81% in patients with thymoma and 47% in patients with TC. TET-related deaths predominated in TC, yielding a cancer-specific survival) of 53% compared with 96% in thymoma. Reduced OS was associated with increasing age (p &lt; 0.001) and advanced Tumor, Node, Metastasis-stage (III p &lt; 0.05; IV p &lt; 0.001). Disease progression was verified in 13\/201 (6%) of thymoma patients with R0 or R1 resection.Interpretation: We report a high OS of Danish TET patients compared to existing population-based studies. The occurrence of TET-related mortality and disease progression in patients with thymoma and TC, highlights the need for long-term follow-up and therefore risk stratification in TET management.<\/jats:p>","DOI":"10.2340\/1651-226x.2026.45407","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:40:12Z","timestamp":1779356412000},"page":"460-467","source":"Crossref","is-referenced-by-count":1,"title":["Survival and relapse of Danish patients with thymic epithelial tumors"],"prefix":"10.2340","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7711-605X","authenticated-orcid":false,"given":"Tine","family":"\u00d8stergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Van Alstine","family":"Bjerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2283-3535","authenticated-orcid":false,"given":"Eric","family":"Santoni-Rugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5622-9347","authenticated-orcid":false,"given":"Thomas Hartvig Lindk\u00e6r","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Anne","family":"Perell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-1869","authenticated-orcid":false,"given":"Ren\u00e9 Horsleben","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9261-0938","authenticated-orcid":false,"given":"Peter Meidahl","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"156318","doi-asserted-by":"crossref","unstructured":"Shin DW, Cho JH, Ha J, Jung KW. Trends in incidence and survival of patients with thymic epithelial tumor in a high-incidence Asian country: analysis of the Korean Central Cancer Registry 1999 to 2017. J Thorac Oncol. 2022;17(6):827\u201337.","DOI":"10.1016\/j.jtho.2022.02.001"},{"key":"156319","doi-asserted-by":"crossref","unstructured":"\u00d8stergaard T, Bjerke CVA, Santoni-Rugiu E, Jensen THL, Perell KA, Petersen RH, et al. Incidence, characteristics, and comorbidities of a complete unselected Danish cohort of patients with thymic epithelial tumors. Acta Oncol. 2025;64:41\u20136.","DOI":"10.2340\/1651-226X.2025.41295"},{"key":"156320","unstructured":"Thoracic tumours. In: WHO Classification of Tumours Editorial Board (ed.). WHO classification of tumours. 5th ed. Lyon: IARC Publications; 2021. p. 319\u2013399."},{"key":"156321","doi-asserted-by":"crossref","unstructured":"Ruffini E, Detterbeck F, van raemdonck D, Rocco G, Thomas P, Weder W, et al. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardio Thorac Surg. 2014;46(3):361\u20138.","DOI":"10.1093\/ejcts\/ezt649"},{"key":"156322","doi-asserted-by":"crossref","unstructured":"Weis CA, Yao X, Deng Y, Detterbeck FC, Marino M, Nicholson AG, et al. The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol. 2015;10(2):367\u201372.","DOI":"10.1097\/JTO.0000000000000393"},{"key":"156323","doi-asserted-by":"crossref","unstructured":"Weksler B, Nason KS, MacKey D, Gallagher A, Pennathur A. Thymomas and extrathymic cancers. Ann Thorac Surg. 2012;93(3):884\u20138.","DOI":"10.1016\/j.athoracsur.2011.05.089"},{"key":"156324","doi-asserted-by":"crossref","unstructured":"Padda SK, Yao X, Antonicelli A, Riess JW, Shang Y, Shrager JB, et al. Paraneoplastic syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group Retrospective Database. J Thorac Oncol. 2018;13(3):436\u201346.","DOI":"10.1016\/j.jtho.2017.11.118"},{"key":"156325","doi-asserted-by":"crossref","unstructured":"Benitez JC, Boucher ME, Dansin E, Kerjouan M, Bigay-Game I, Pichon E, et al. 53P Studying autoimmune diseases with thymic epithelial tumors (TET): real-world insight from RYTHMIC. Ann Oncol. 2020;31:S1437.","DOI":"10.1016\/j.annonc.2020.10.540"},{"key":"156326","doi-asserted-by":"crossref","unstructured":"Tseng YL, Chang JM, Lai WW, Chang KC, Lee SC, Lin SH, et al. Behind and beyond the masaoka staging: a 25-year follow-up study of tumor recurrence in completely resected thymic epithelial tumors in a single institution. Medicine. 2015;94(52):e2278.","DOI":"10.1097\/MD.0000000000002278"},{"key":"156327","doi-asserted-by":"crossref","unstructured":"Hamaji M, Sozu T, MacHida R, Watanabe SI, Yoshida K, Toyooka S, et al. Mortality from extrathymic malignancy after thymic tumour resections: incidences and risk factors. Interact Cardiovasc Thorac Surg. 2019;29(5):729\u201336.","DOI":"10.1093\/icvts\/ivz177"},{"key":"156328","doi-asserted-by":"crossref","unstructured":"Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bj\u00f6rkholm M, Landgren O, et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer. 2011;128(11):2688\u201394.","DOI":"10.1002\/ijc.25583"},{"key":"156329","doi-asserted-by":"crossref","unstructured":"Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci. 2010;290(1\u20132):66\u20139.","DOI":"10.1016\/j.jns.2009.11.006"},{"key":"156330","doi-asserted-by":"crossref","unstructured":"Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v40\u201355.","DOI":"10.1093\/annonc\/mdv277"},{"key":"156331","unstructured":"Petersen PM, Kalhauge A, Brandt B, Santoni-Rugiu E, Daugaard G, Ravn J, et al. Behandling af tymom og thymuskarcinom. Ugeskrift L\u00e6ger. 2020;182:2\u20136."},{"key":"156332","doi-asserted-by":"crossref","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Clinical epidemiology existing data sources for clinical epidemiology: the Danish national Pathology registry and Data Bank. Clin Epidemiol. 2010;2:51\u20136.","DOI":"10.2147\/CLEP.S9908"},{"key":"156333","unstructured":"UICC. TNM classification of malignant tumours. 8th ed. Brierley JD, editor. Geneva: UICC; 2016."},{"key":"156334","unstructured":"The R Foundation for Statistical Computing. R statistical software [Internet]. Vienna: R Foundation for Statistical Computing; 2024 [cited 2024 Sep 3]. Available from: https:\/\/www.R-project.org\/"},{"key":"156335","unstructured":"RStudio Team. RStudio [Internet]. Boston (MA): Posit Software, PBC; 2024. Available from: https:\/\/posit.co\/"},{"key":"156336","doi-asserted-by":"crossref","unstructured":"de Jong WK, Blaauwgeers JLG, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJM. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008;44(1):123\u201330.","DOI":"10.1016\/j.ejca.2007.11.004"},{"key":"156337","doi-asserted-by":"crossref","unstructured":"Borg M, Hilberg O, Andersen MB, Weinreich UM, Rasmussen TR. Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings. Acta Oncol (Madr). 2022;61(10):1256\u201362.","DOI":"10.1080\/0284186X.2022.2135134"},{"key":"156338","doi-asserted-by":"crossref","unstructured":"Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15(1):82\u201392.","DOI":"10.1016\/j.autrev.2015.09.005"},{"key":"156339","doi-asserted-by":"crossref","unstructured":"Li Y, Jiang A, Zhao Y, Shi C, Ma Y, Fu X, et al. A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: a population-based study. Front Endocrinol (Lausanne). 2022;13:1050364.","DOI":"10.3389\/fendo.2022.1050364"},{"key":"156340","doi-asserted-by":"crossref","unstructured":"Liu M, Wang C, Gao L, Lv C, Fu X. Clinical significance of age at diagnosis among patients with thymic epithelial tumors: a population-based study. Aging. 2020;12(6):4815\u201321.","DOI":"10.18632\/aging.102897"},{"key":"156341","doi-asserted-by":"crossref","unstructured":"Yun JK, Kim HR, Kim DK, Shim YM, Kim YT, Chung KY, et al. Tumor size as a prognostic factor in limited-stage thymic epithelial tumors: a multicenter analysis. J Thorac Cardiovasc Surg. 2021;162(1):309\u201317.e9.","DOI":"10.1016\/j.jtcvs.2020.05.048"},{"key":"156342","doi-asserted-by":"crossref","unstructured":"Margaritora S, Cesario A, Cusumano G, Meacci E, D\u2019Angelillo R, Bonassi S, et al. Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg. 2010;89(1):245\u201352.","DOI":"10.1016\/j.athoracsur.2009.08.074"},{"key":"156343","doi-asserted-by":"crossref","unstructured":"Liu H, Gu ZT, Qiu B, Detterbeck FC, Roden AC, Ruffini E, et al. A recurrence predictive model for thymic tumors and its implication for postoperative management: a Chinese Alliance for Research in Thymomas Database Study. J Thorac Oncol. 2020;15(3):448\u201356.","DOI":"10.1016\/j.jtho.2019.10.018"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45407\/54040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45407\/54040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:40:26Z","timestamp":1779356426000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/45407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2026.45407","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}